Changeflow GovPing Pharma & Drug Safety Beta Ketoacyl Synthase IV Variants by CORBION B...
Routine Rule Added Final

Beta Ketoacyl Synthase IV Variants by CORBION BIOTECH

Favicon for changeflow.com USPTO Patent Grants - Peptides (C07K)
Published
Detected
Email

Summary

USPTO granted Patent US12600994B2 to CORBION BIOTECH, INC. covering non-natural variant β-ketoacyl-ACP synthase (KAS) IVa enzymes, polynucleotides encoding such variants, host cells expressing such variants, and oils and oil products produced by such cells. The patent names Joshua Ferreira, Janice Lau Wee, and Nien-Hsi Ko as inventors. Filing date was January 15, 2021, with 21 claims granted.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO issued Patent US12600994B2 to Corbion Biotech, Inc. for variant β-ketoacyl-ACP synthase IVa (KASIVa) enzymes and related compositions including polynucleotides encoding the variants, host cells expressing them, and oils and oil products produced by such cells.

For parties in the biotechnology, enzyme manufacturing, or oil/fatty acid production industries, this patent grant establishes intellectual property protection for Corbion Biotech covering engineered KASIVa enzymes used in oil biosynthesis. Potential licensees or developers of similar enzyme variants should review claims to assess infringement risk or freedom-to-operate considerations.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

β-ketoacyl-ACP synthase IV variants

Grant US12600994B2 Kind: B2 Apr 14, 2026

Assignee

CORBION BIOTECH, INC.

Inventors

Joshua Ferreira, Janice Lau Wee, Nien-Hsi Ko

Abstract

Provided are non-natural or variant β-ketoacyl-acyl carrier protein (ACP) synthase (KAS) IVa enzymes (KASIVa), polynucleotides encoding such variant KASIVa, host cells expressing such variant KASIVa, oils and oil products produced by such cells, and methods of making and using such variant KASIVa.

CPC Classifications

C12P 7/6445 C12N 9/1029 C12N 9/16 C12N 15/62 C12N 15/74 C12Y 203/01041 C07K 2319/01 C07K 2319/42 C07K 2319/43

Filing Date

2021-01-15

Application No.

17793123

Claims

21

View original document →

Get daily alerts for USPTO Patent Grants - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12600994B2

Who this affects

Applies to
Biotechnology companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent grant Biotechnology Enzyme manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Chemicals

Get alerts for this source

We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!